The purpose of this requirement is to 1) provide medical countermeasures (mcms), such as vaccines and adjuvants, for pandemic preparedness and response or as required in response to a HHS designated…
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75A50122D00004
- Awardee
-
Seqirus Inc. UEI Z6N1LJ2RD6E3
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Task orders
- 15 $134,769,408 obligated
Award facts
- Opportunity
-
- Acquisition of Medical Countermeasures (MCMs) for Pandemic Influenza and Emerging Diseases Preparedness and Response Solicitation · 75A50121R00013 · Posted Jun 29, 2021
- Combined order value
-
- $134,769,408 Current, with exercised options
- $509,935,977 Potential, with all options
- Last date to order 93% complete
- IDV ceiling 1% used
- $13,399,072,878.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a single-award Indefinite Delivery Contract valued at $13.4 billion to Seqirus Inc., a division of CSL Seqirus, on February 22, 2022, with an ultimate completion date of February 21, 2027. This contract vehicle was established to acquire medical countermeasures, including vaccines and adjuvants, for pandemic preparedness and response to public health emergencies designated by HHS. The contract encompasses a comprehensive scope of services including the production of influenza vaccine master and working seed lots, investigational and commercial bulk vaccine lots, formulation and filling of vaccine doses, stability studies and testing, storage and maintenance of vaccine stockpiles, and specialized research support such as physical and chemical compatibility studies. All work is performed at Seqirus's manufacturing facility in Holly Springs, North Carolina. The contract utilizes firm fixed-price delivery orders with no set-aside designation and serves as the primary procurement mechanism for HHS ASPR to rapidly acquire critical medical countermeasures from this supplier.
Under the parent Indefinite Delivery Contract, HHS ASPR has issued multiple delivery orders totaling over $116 million to date, covering a diverse range of pandemic preparedness initiatives. Significant task orders include a $349.3 million order for H5 pandemic readiness medical countermeasures, a $30.7 million order for influenza A/Astrakhan/3212/2020 (H5N8)-like master and working seed lots, a $28.5 million order for H5N8 antigen acquisition and formulation, and a $23.3 million order for storage and stability testing of vaccine bulk lots. Additional smaller task orders address antigen and adjuvant storage, compatibility studies, and related vaccine development activities. The original solicitation, posted in June 2021, specified requirements for cGMP manufacturing of up to three lots of influenza vaccine master seed stock annually, formulation and filling of at least 50 million vaccine doses annually, and comprehensive stability testing and storage services across a five-year base period with two twelve-month option periods. This contract structure enables HHS ASPR to maintain critical stockpiles and rapidly respond to emerging infectious disease threats and pandemic preparedness requirements.
Description
The purpose of this requirement is to 1) provide medical countermeasures (mcms), such as vaccines and adjuvants, for pandemic preparedness and response or as required in response to a HHS designated public health emergency. 2) produce vaccines AG
Task orders
Show all 15
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Show all 15
Quick answers
Who was awarded contract 75A50122D00004?
75A50122D00004 was awarded to Seqirus Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on February 22, 2022.
How much is contract 75A50122D00004 worth?
Orders under 75A50122D00004 have obligated $134,769,408. Their combined potential value, with all options, is $509,935,977. 75A50122D00004's own ceiling is $13,399,072,878.
How many orders have been placed under contract 75A50122D00004?
15 orders have been placed under 75A50122D00004, the latest on September 30, 2026.
Who can order from contract 75A50122D00004?
75A50122D00004 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75A50122D00004 competed?
The extent of competition for 75A50122D00004 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV